Migraine affects 1 in 6 people worldwide - that's over 1 billion people! With more than 30 drugs available for migraine, and few clinical distinctions between migraine subtypes, it is impossible for clinicians to know which treatment is best for a particular patient.
N-Health is a companion app for the Neurolytic Healthcare Migraine Study, a study which aims to develop a solution to this problem. Using cutting edge digital biomarker technology and genomic information, we hope to be able to get every patient on the right treatment for them.
N-Health is a companion app for the Neurolytic Healthcare Migraine Study, a study which aims to develop a solution to this problem. Using cutting edge digital biomarker technology and genomic information, we hope to be able to get every patient on the right treatment for them.
Show More
